India ceftriaxone market is forecasted
to grow at a steady pace during the forecast period. Ceftriaxone is an
antibiotic which is utilized for curing a number of bacterial infections. The
India ceftriaxone market is driven by surging population with urinary tract
(UTI) and skin infections in India. Additionally, government initiatives for spreading
awareness coupled with high investments for research activities by major market
players are some other factors which is projected to bolster the market growth.
Also, the medication is a popular drug choice for the treatment of bacterial
meningitis which is further expected to boost the demand through FY2026.
The India ceftriaxone market is
segmented based on dose, source, form, distribution channel, application, end user, company, and region. Based on form,
the market can be segmented into intramuscular injection, intravenous
injection, infusion, others. The intramuscular injection segment is expected to
grow at a highest CAGR in the market over the next 5 years because intramuscular
injections are used as an alternative to intravenous injections because some
drugs are irritating to veins. Along with this, sometimes a suitable vein cannot
be located, which is another major reason boosting its demand, thus estimated
to drive the segmental growth in near future.
The major players operating in the India
ceftriaxone market are Radicura Pharmaceuticals Pvt. Ltd, Wockhardt Limited
(Taurus), Nectar Lifesciences Ltd., Qilu Pharmaceutical India Pvt. Ltd.,
Mankind Pharma Ltd., Fresenius Kabi India Pvt. Ltd., Virchow Healthcare Private
Limited, Orchid Pharma Ltd., Ikon Remedies Pvt. Ltd., IPCA Laboratories Ltd,
and others. Major companies are developing advanced technologies, receiving
approvals from regulatory bodies, and launching new products in order to stay
competitive in the market. Other competitive strategies include mergers &
acquisitions, portfolio expansions and new product developments.
Years
considered for this report:
Historical Years: FY2016-FY2019
Base Year: FY2020
Estimated Year: FY2021
Forecast Period: FY2022–FY2026
Objective of the Study:
- To analyze and estimate the market size of India ceftriaxone market
from FY2016 to FY2019.
- To estimate and forecast the market size of India ceftriaxone market
from FY2020 to FY2026 and growth rate until FY2026.
- To classify and forecast India ceftriaxone market based on dose,
source, form, distribution channel, application, end user, company, and
regional distribution.
- To identify dominant region or segment in the India ceftriaxone market.
- To identify drivers and challenges for India ceftriaxone market.
- To examine competitive developments such as expansions, new product
launches, mergers & acquisitions, etc., in India ceftriaxone market.
- To identify and analyze the profile of leading players operating in
India ceftriaxone market.
- To identify key sustainable strategies adopted by market players in
India ceftriaxone market.
Click here to download the sample
TechSci Research performed both primary as well as exhaustive
secondary research for this study. Initially, TechSci Research sourced a list
of manufacturers across the globe. Subsequently, TechSci Research conducted
primary research surveys with the identified companies. While interviewing, the
respondents were also enquired about their competitors. Through this technique,
TechSci Research could include the manufacturers which could not be identified
due to the limitations of secondary research. TechSci Research analyzed the
manufacturers, distribution channels and presence of all major players across
the globe.
TechSci
Research calculated the market size of India ceftriaxone market using a bottom-up approach, wherein data for various end-user segments
was recorded and forecast for the future years. TechSci Research sourced these
values from the industry experts and company representatives and externally
validated through analyzing historical data of these product types and
applications for getting an appropriate, overall market size. Various secondary
sources such as company websites, news articles, press releases, company annual
reports, investor presentations and financial reports were also studied by
TechSci Research.
Key Target Audience:
- Ceftriaxone manufacturers/ suppliers/
distributors
- Market research and consulting firms
- Government bodies such as regulating
authorities and policy makers
- Organizations, forums and alliances related to
ceftriaxone
The study is useful in providing answers to several critical
questions that are important for the industry stakeholders such as manufacturers,
suppliers and partners, end users, etc., besides allowing them in strategizing
investments and capitalizing on market opportunities.
Report Scope:
In this report, India ceftriaxone market has
been segmented into following categories, in addition to the industry trends
which have also been detailed below:
- India Ceftriaxone Market, By Dose:
- 100 mg
- 200 mg
- 250 mg
- 500 mg
- Others
- India Ceftriaxone Market, By Source:
- In-house
- Contract
Manufacturing Organizations
- India Ceftriaxone Market, By Form:
- Intramuscular
Injection
- Intravenous
Injection
- Infusion
- Others
- India Ceftriaxone Market, By Distribution Channel:
- India Ceftriaxone Market, By Application:
- Endocarditis
- Meningitis
- Pneumonia
- Bone and
Joint Infections
- Intra-Abdominal
Infections
- Skin
Infections
- Urinary
Tract Infections
- Gonorrhoea
- Others
- India Ceftriaxone Market, By End User:
- India Ceftriaxone Market, By Region:
Competitive
Landscape
Company Profiles: Detailed analysis of the major
companies present in India ceftriaxone market.
Available Customizations:
With the given market data, TechSci Research offers
customizations according to a company’s specific needs. The following
customization options are available for the report:
Company Information
- Detailed analysis and
profiling of additional market players (up to five).
India ceftriaxone market is
an upcoming report to be released soon. If you wish an early delivery of this
report or want to confirm the date of release, please contact us at [email protected]